dismiss

Clean Sweep Live Auction on Wed. May 1st. Click to view the full inventory

DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Pediatrics
SEARCH
Current Location:
>
>
> This Story

Forward Printable StoryPrint Comment
advertisement

 

advertisement

 

Molecular Imaging Homepage

Zionexa completes a second $5 million capital raise

SNMMI and ACR collaborate on clinical data registry for nuclear medicine

New PET imaging biomarker could better predict progression of Alzheimer's disease

MILabs installs new E-Class SPECT/CT system to enhance heart failure research at CHFC in Germany

Nordion and BRIT collaborate to bring cobalt-60 from India to global markets

Bruce Power completes harvest of Cobalt-60 that will save lives through cancer treatments

Nordion and Tong Xing expand cobalt-60 supply agreement

Advanced imaging technology predicts cardiovascular risk from inflammation detected in arteries

TRIUMF receives historic investment in 2019 federal budget

Enigma Biomedical Group signs license agreement with Merck for novel MK-6884 imaging agent

DOSIsoft PLANET Onco Dose receives FDA clearance for molecular imaging & molecular radiotherapy dosimetry

Press releases may be edited for formatting or style
DOSIsoft, leading provider of advanced software solutions for Radiation Oncology and Nuclear Medicine, is pleased to announce it has received on March 7th, 2019, from the US Food and Drug Administration (FDA), the 510(k) clearance to market PLANET® Onco Dose software, for its Oncology and Yttrium-90 microsphere SIRT 3D Dosimetry components.

An integrated imaging and dosimetry platform dedicated to Molecular Imaging & Molecular Radiotherapy Dosimetry

Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED



PLANET® Onco Dose is a comprehensive software platform dedicated to medical diagnosis aid, therapy response assessment aid, contouring for radiotherapy and internal dosimetry computation, using molecular imaging modalities.

PLANET® Onco Dose is a modular software suite composed of two main elements:
- PLANET® Onco: The Oncology module with core System features, comprehensive reviewing of multimodal molecular image series (CT, MRI, PET, SPECT), fusion and registration, automatic and semi-automatic contouring of regions of interest, tumor segmentation, quantification, tumoral activity monitoring, therapy response assessment;
- PLANET® Dose: The Dosimetry module including 3D personalized voxel-based internal dosimetry computation dedicated to Molecular Radiotherapy (MRT)

PLANET® Onco provides advanced tools to display, co-register (including deformable registration), compute Standardized Uptake Value and import / export results (contours and quantification results) to / from Treatment Planning Systems and PACS devices for assessment, treatment planning and response of patients undergoing a course of oncology treatments.

A personalized 3D dosimetry solution for 90Yttrium-based Selective Internal Radiation Therapy

Leveraging its long-term experience, DOSIsoft has transferred its External Radiation Therapy advanced software technology to Nuclear Medicine and Molecular Radiotherapy. CE marked since March 2016, PLANET® Onco Dose is the first fully integrated imaging and personalized 3D dosimetry platform for radionuclide-based therapies.

PLANET® Onco Dose is intended to assist the user in the diagnosis, quantification and verification of radiation doses received by tissues as a result of administering permanent Yttrium-90 (90Y) microsphere implants, as well as in therapy response follow-up.

PLANET® Onco Dose provides tools for post-treatment absorbed dose calculation and evaluation on PET and SPECT images. The following functions are available to allow dose calculations for patients after they have received a treatment using permanent Yttrium-90 microspheres:
  Pages: 1 - 2 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2019 DOTmed.com, Inc.
ALL RIGHTS RESERVED